Millipore Sigma Vibrant Logo

553506 RAP, Human, Recombinant, E. coli

View Products on Sigmaaldrich.com
553506
  
Prix en cours de récupération
Le prix n'a pas pu être récupéré
La quantité minimale doit être un multiple de
Maximum Quantity is
À la validation de la commande Plus d'informations
Vous avez sauvegardé ()
 
Demander le prix
Disponibilité limitée
Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

       

      Contacter le Service Clients

      Aperçu

      Replacement Information
      Description
      OverviewRecombinant, human RAP fused to GST, expressed in E. coli, and subsequently cleaved with thrombin to remove GST. Antagonizes the ligand binding of certain members of the low-density lipoprotein receptor family such as low density lipoprotein receptor-related protein (LRP) and very low-density lipoprotein (VLDL) receptor. Promotes the proper folding and subsequent exocytic trafficking of the wild-type low density lipoprotein receptor (LDLR) and several of its class 2 mutants. Expressed as a GST-fusion protein that is subsequently cleaved with thrombin. Typical concentrations to block LRP or VLDL receptor are 200-300 nM. For antagonism of LDLR, 1 µM is recommended.
      Catalogue Number553506
      Brand Family Calbiochem®
      SynonymsReceptor Associated Protein
      References
      ReferencesLi, Y., et al. 2002. Biochemistry 41, 4921.
      Salicioni, A.M., et al. 2002. J. Biol. Chem. 277, 16160.
      Anderson, O.M., et al. 2001. Biochemistry 40, 15408.
      Bu, G. 2001. Int. Rev. Cytol. 209, 79.
      Williams, S.E., et al. 1992. J. Biol. Chem. 267, 9035
      Product Information
      FormLiquid
      Formulation150 mM NaCl, 100 mM Tris-HCl, pH 7.4.
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥90% by SDS-PAGE
      Concentration Label Please refer to vial label for lot-specific concentration
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Dry Ice Only
      Toxicity Standard Handling
      Storage ≤ -70°C
      Avoid freeze/thaw Avoid freeze/thaw
      Do not freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C).
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      553506 0

      Documentation

      RAP, Human, Recombinant, E. coli FDS

      Titre

      Fiche de données de sécurité des matériaux (FDS) 

      RAP, Human, Recombinant, E. coli Certificats d'analyse

      TitreNuméro de lot
      553506

      Références bibliographiques

      Aperçu de la référence bibliographique
      Li, Y., et al. 2002. Biochemistry 41, 4921.
      Salicioni, A.M., et al. 2002. J. Biol. Chem. 277, 16160.
      Anderson, O.M., et al. 2001. Biochemistry 40, 15408.
      Bu, G. 2001. Int. Rev. Cytol. 209, 79.
      Williams, S.E., et al. 1992. J. Biol. Chem. 267, 9035
      Fiche technique

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision20-April-2009 JSW
      SynonymsReceptor Associated Protein
      DescriptionRecombinant, human RAP fused to GST, expressed in E. coli, and subsequently cleaved with thrombin to remove GST. Receptor Associated Protein (RAP) antagonizes the ligand binding of certain members of the low-density lipoprotein receptor family such as low-density lipoprotein receptor-related protein (LRP) and very low density lipoprotein (VLDL) receptor. Promotes the proper folding and subsequent exocytic trafficking of the wild-type low-density lipoprotein receptor (LDLR) and several of its class 2 mutants. Typical concentrations used to block LRP or VLDL receptor are 200-300 nM; for antagonism of LDLR, 1 µM is recommended.
      FormLiquid
      Formulation150 mM NaCl, 100 mM Tris-HCl, pH 7.4.
      Concentration Label Please refer to vial label for lot-specific concentration
      Purity≥90% by SDS-PAGE
      Storage Avoid freeze/thaw
      ≤ -70°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C).
      Toxicity Standard Handling
      ReferencesLi, Y., et al. 2002. Biochemistry 41, 4921.
      Salicioni, A.M., et al. 2002. J. Biol. Chem. 277, 16160.
      Anderson, O.M., et al. 2001. Biochemistry 40, 15408.
      Bu, G. 2001. Int. Rev. Cytol. 209, 79.
      Williams, S.E., et al. 1992. J. Biol. Chem. 267, 9035